PHARMACEUTICAL COMPOSITION COMPRISING GLUCOPYRANOSYL DIPHENYLMETHANE DERIVATIVES, PHARMACEUTICAL DOSAGE FORM THEREOF, PROCESS FOR THEIR PREPARATION AND USES THEREOF FOR IMPROVED GLYCEMIC CONTROL IN A PATIENT
594024 Disclosed herein is pharmaceutical composition comprising a SGLT-2 inhibitor, specifically a compound of formula (I.9) wherein the variables are defined in the specification, wherein the particle size distribution in said composition is 1?m ? X90 <; 200 ?m, and wherein said compound of the formula (I.9) represents 25% or less of the weight of said composition. Additionally disclosed are pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.